Evaluation status available after sign-in
About the journal
Hematología is an open-access journal published by Sociedad Argentina de Hematología in Argentina, publishing in english and spanish. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 4 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Sociedad Argentina de Hematología
- ISSN
- 0329-0379 · 2250-8309
- Country
- Argentina
- Languages
- english, spanish
- Access
- Open access
- Articles in DOAJ
- 0
- Declared review time
- 4 weeks
- Declared peer-review model
- double_blind
- Official website
- http://www.revistahematologia.com.ar
Index listings
- DOAJ · 2020-05-01
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 4 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
4weeks
Works in OpenAlex
159
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
2
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2020-05-01
- Added to DOAJ
- 2020-05-01
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- PKP PN
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 19%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
LCC codes
RC633-647.5
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Hematological disorders and diagnostics
- Chronic Lymphocytic Leukemia Research
- Blood Coagulation and Thrombosis Mechanisms
Show all subjects (75)
- Acute Lymphoblastic Leukemia research
- Retinoids in leukemia and cellular processes
- Viral-associated cancers and disorders
- Multiple Myeloma Research and Treatments
- Hemophilia Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Chronic Myeloid Leukemia Treatments
- COVID-19 Clinical Research Studies
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
- Clinical Laboratory Practices and Quality Control
- CNS Lymphoma Diagnosis and Treatment
- Complement system in diseases
- Acute Myeloid Leukemia Research
- Neutropenia and Cancer Infections
- Blood groups and transfusion
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Biographical and Historical Analysis
- History of Science and Medicine
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Venous Thromboembolism Diagnosis and Management
- Hemophilia Treatment and Research
- Hemophilia Treatment and Research
- Venous Thromboembolism Diagnosis and Management
- Viral-associated cancers and disorders
- Chronic Myeloid Leukemia Treatments
- Viral-associated cancers and disorders
- Chronic Myeloid Leukemia Treatments
- Blood disorders and treatments
- Atrial Fibrillation Management and Outcomes
- Cutaneous lymphoproliferative disorders research
- Blood disorders and treatments
- Iron Metabolism and Disorders
- Cutaneous lymphoproliferative disorders research
- Atrial Fibrillation Management and Outcomes
- Iron Metabolism and Disorders
- Medical research and treatments
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Histiocytic Disorders and Treatments
- Medical research and treatments
- Neutropenia and Cancer Infections
- Health and Medical Education
- Neutropenia and Cancer Infections
- Health and Medical Education
- Histiocytic Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Blood transfusion and management
- Blood transfusion and management
- Hemoglobinopathies and Related Disorders
- Hematopoietic Stem Cell Transplantation
- COVID-19 Clinical Research Studies
- Hemoglobinopathies and Related Disorders
- COVID-19 Clinical Research Studies
Keywords (DOAJ)
- hematology
- medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ